首页> 外国专利> Novel crystalline pamidronate disodium hydrate and process for producing the same

Novel crystalline pamidronate disodium hydrate and process for producing the same

机译:新型结晶帕米膦酸二钠水合物及其制备方法

摘要

The present invention relates to a novel crystalline disodium pamidronate 3~4 hydrate and a process for preparing it. More particularly, crystalline disodium pamidronate 3~4 hydrate of the following formula I having the water content of 17.0~20.0 wt % and being in the state of the mixture of trihydrate and tetrahydrate is prepared by neutralizing pamidronic acid with sodium compound, drying the formed disodium pamidronate, dissolving the disodium pamidronate in water, filtering sparingly soluble materials, allowing the filtrate to stand with stirring at normal temperature to form crystals, cooling and filtering the mixture to obtain crystals, and drying at the temperature of 75~85° C. under normal pressure.The novel disodium pamidronate 3~4 hydrate according to the present invention is much more stable compound structurally than the known disodium pamidronate pentahydrate. When the compound is in storage or is used as pharmaceutical formulations, validity time can be prolonged and it can be formulated as convenient oral preparations such as soft capsule in addition to injections.
机译:本发明涉及一种新型的结晶的帕米膦酸钠3〜4水合物结晶及其制备方法。更具体地,通过用钠化合物中和帕米膦酸,将所形成的结晶式的帕米膦酸二钠3〜4水合物,其水含量为17.0〜20.0重量%并且处于三水合物和四水合物的混合物的状态,来制备。将帕米膦酸二钠溶解在水中,过滤微溶的物质,使滤液在常温搅拌下静置以形成晶体,冷却并过滤混合物以获得晶体,并在75〜85°C的温度下干燥。本发明的新型帕米膦酸二钠3-4水合物在结构上比已知的五水帕米膦酸二钠稳定得多。当该化合物贮存或用作药物制剂时,可以延长有效时间,并且可以将其配制成方便的口服制剂,例如除注射剂外的软胶囊。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号